Bulletin
Investor Alert

Indaptus Therapeutics Inc.

NAS: INDP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 28, 2023, 5:00 p.m.

/zigman2/quotes/204811863/composite

$

1.95

Change

+0.19 +10.80%

Volume

Volume 20

Quotes are delayed by 20 min

/zigman2/quotes/204811863/composite

Today's close

$ 1.82

$ 1.76

Change

-0.06 -3.03%

Day low

Day high

$1.75

$1.81

Open

52 week low

52 week high

$1.25

$4.25

Open

Annual Financials for Indaptus Therapeutics Inc.

Fiscal year is February-January. All values USD millions. 20212020201920182017 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A 1,403852854,000859,000829,000
COGS excluding D&A -----
Depreciation & Amortization Expense -852--829,000
Depreciation -852--829,000
Amortization of Intangibles -----
Gross Income (1,403)(852)(854,000)(859,000)(829,000)
20212020201920182017 5-year trend
SG&A Expense 7.73M3.6M34.09M42.47M28.61M
Research & Development -2.66M--24.3M
Other SG&A 5.2M943,3967.43M7.07M4.32M
Other Operating Expense -----
Unusual Expense --13.65M194,000(220,000)
EBIT after Unusual Expense --(48.6M)(43.52M)220,000
Non Operating Income/Expense -15,110--70,000
Non-Operating Interest Income ----286,000
Equity in Affiliates (Pretax) -----
Interest Expense --15,00023,00017,000
Gross Interest Expense ----17,000
Interest Capitalized -----
Pretax Income (7.71M)(3.58M)(46.96M)(43.44M)(28.88M)
Income Tax --638,000103,00029,000
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (7.71M)(3.58M)(47.6M)(43.54M)(28.91M)
Minority Interest Expense -----
Net Income (7.71M)(3.58M)(47.6M)(43.54M)(28.91M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (7.71M)(3.58M)(47.6M)(43.54M)(28.91M)
Preferred Dividends -----
Net Income Available to Common (7.71M)(3.58M)(47.6M)(43.54M)(28.91M)
EPS (Basic) (1.89)(7.37)(112.74)(111.67)(130.96)
Basic Shares Outstanding 4.09M486,168422,200389,913220,750
EPS (Diluted) (1.89)(7.37)(112.74)(111.67)(130.96)
Diluted Shares Outstanding 4.09M486,168422,200389,913220,750
EBITDA (7.73M)(3.6M)(34.09M)(42.47M)(28.61M)
Link to MarketWatch's Slice.